CONCENTRA GROUP HOLDINGS PARENT IN (CON)
Sector: Health Care
2026 Annual Meeting Analysis
CONCENTRA GROUP HOLDINGS PARENT IN · Meeting: April 30, 2026
Directors FOR
3
Directors AGAINST
0
Say on Pay
FOR
Auditor
FOR
Director Elections
Election of Class II Directors
Newton has served as director since June 2024 (under 24 months), exempting him from the TSR trigger; he brings deep operational knowledge as CEO with nearly 30 years of healthcare industry experience and no overboarding, attendance, or independence concerns.
Watkins has served since July 2024 (under 24 months), exempting him from the TSR trigger; he is an independent director with deep healthcare and clinical expertise, no overboarding concerns, and attended all board and committee meetings.
Gopal has served since July 2025 (well under 24 months), fully exempting him from the TSR trigger; he brings valuable data analytics and AI experience relevant to the company's healthcare strategy and no overboarding or attendance concerns are present.
All three Class II nominees — CEO William Newton, independent director Marc Watkins, and independent director Vipin Gopal — joined within the past 24 months and are therefore exempt from the TSR underperformance trigger under policy. No overboarding, attendance, independence, familial relationship, or qualification concerns are identified for any nominee. The board discloses a skills matrix. Vote FOR all three.
Say on Pay
✓ FORCEO
William K. Newton
Total Comp
$7,399,513
Prior Support
78.4%%
The prior year say-on-pay vote received 78.4% support, well above the 70% threshold that would require visible remediation. CEO total compensation of $7,399,513 is within a reasonable range for a healthcare services CEO at a ~$2.9 billion market cap company, and the pay mix is heavily weighted toward variable compensation — approximately 89% of total pay is variable (equity awards of $4,356,000 plus performance bonus of $2,125,000 versus base salary of $843,077), which comfortably exceeds the 50-60% policy threshold. The company has a NYSE-compliant clawback policy and stock ownership guidelines in place, and the incentive plan uses EBITDA and EPS targets with defined threshold, target, and maximum levels, representing meaningful performance conditions.
Auditor Ratification
✓ FORAuditor
PricewaterhouseCoopers LLP
Tenure
N/A
Audit Fees
$2,186,000
Non-Audit Fees
$2,000
Non-audit fees of $2,000 represent well under 1% of audit fees of $2,186,000, far below the 50% threshold that would trigger a concern; PwC is a Big 4 firm fully appropriate for a $2.9 billion market cap company; no restatements are disclosed and auditor tenure is not stated so the tenure trigger does not fire under policy.
Overall Assessment
Concentra's 2026 annual meeting ballot contains three standard proposals: director elections, say-on-pay, and auditor ratification. All proposals pass the applicable policy screens cleanly — the director nominees are all recent appointees exempt from the TSR trigger, PwC's non-audit fees are negligible, and executive pay is structured with a strong performance-based orientation supported by adequate prior shareholder approval.